Get the Stockscreener App
1.92
13.61%
0.23
After Hours:
1.88
-0.04
-2.08%
Seer Inc stock is traded at $1.92, with a volume of 3.35M.
It is up +13.61% in the last 24 hours and up +6.08% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$1.69
Open:
$1.85
24h Volume:
3.35M
Relative Volume:
10.96
Market Cap:
$108.33M
Revenue:
$16.45M
Net Income/Loss:
$-73.60M
P/E Ratio:
-1.5006
EPS:
-1.2795
Net Cash Flow:
$-46.25M
1W Performance:
+12.28%
1M Performance:
+6.08%
6M Performance:
-13.12%
1Y Performance:
-4.00%
1-Day Range:
$1.82
$1.94
1-Week Range:
$1.665
$1.94
52-Week Range:
$1.65
$2.41
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.92 | 95.35M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
440.05 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.46 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
809.27 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.00 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
305.64 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer (SEER) Receives Acquisition Proposal and Board Nominations - GuruFocus
Seer receives $2.25 per share buyout proposal from investor group By Investing.com - Investing.com Australia
Bradley L. Radoff and Michael Torok submitted a non-binding proposal to acquire remaining 93.81% stake in Seer, Inc. for approximately $130 million. - marketscreener.com
Seer, Inc. Confirms Receipt of Acquisition Proposal from Radoff-JEC Group - Quiver Quantitative
Seer faces $2.25-a-share buyout bid and 3 board nominees - Stock Titan
Radoff-JEC Group Proposes Seer, Inc. Acquisition - National Today
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc. - Investing News Network
Seer Shares Jump On Takeover Proposal - Benzinga
Seer jumps 10% on $2.25 per share all-cash acquisition bid from activist group - MSN
Seer receives $2.25 per share takeover bid from activist investors By Investing.com - Investing.com
Seer (SEER) Faces Acquisition Proposal and Board Nominations - GuruFocus
SEER PE Ratio & Valuation, Is SEER Overvalued - Intellectia AI
Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort - Sahm
US Market Recap: What is the target price for Seer Inc stockTrade Analysis Report & Daily Market Momentum Tracking - baoquankhu1.vn
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples - Investing News Network
Seer, Inc. and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 Precise Sg100k Samples - marketscreener.com
A 100,000-person Singapore health study picks Seer for 10,000 samples - Stock Titan
Seer Inc stock: Why this proteomics innovator merits your attention now - AD HOC NEWS
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries - 富途牛牛
Whale Trades: Can Seer Inc deliver consistent EPS growth2026 Patterns & Weekly Consistent Profit Watchlists - baoquankhu1.vn
BRKR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Fundamentals Check: Is now the right time to enter Seer Inc2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Bruker, Seer Each Claim Partial Win in US Patent Board Ruling - 富途牛牛
Seer, Inc. (NASDAQ:SEER) Sees Large Decline in Short Interest - MarketBeat
Seer retains patent claims in USPTO review of protein analysis tech By Investing.com - Investing.com South Africa
Seer retains patent claims in USPTO review of protein analysis tech - Investing.com Australia
Seer Strengthens Proteograph IP Following Favorable Patent Ruling - TipRanks
PTAB upholds key Seer (Nasdaq: SEER) Proteograph patent claims - Stock Titan
Nasdaq Moves: Whats next for Seer Inc stockAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Bullish Seer Insiders Loaded Up On US$5.29m Of Stock - Yahoo Finance
Risk Recap: Will Seer Inc outperform the market in YEAR2026 Sector Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Seer Inc meet Warren Buffetts criteriaTake Profit & Real-Time Buy Signal Notifications - baoquankhu1.vn
US Market Wrap: Should you avoid Seer Inc stock right now2026 Big Picture & Real-Time Volume Analysis Alerts - baoquankhu1.vn
TD Cowen Maintains Seer Inc(SEER.US) With Buy Rating - 富途牛牛
Seer (NASDAQ:SEER) Shares Down 2.6%Here's What Happened - MarketBeat
SEER Should I Buy - Intellectia AI
SEER.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SEER.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SEER News & Events - Intellectia AI
SEER.O Technical Analysis & Stock Price Forecast - Intellectia AI
Retail Trends: What is the target price for Seer Inc stockProduct Launch & Daily Oversold Bounce Ideas - baoquankhu1.vn
Seer Inc stock (ISIN: US8158581079) gains traction as protein-analysis platform expands clinical ado - AD HOC NEWS
Seer, Inc. Announces Amendment No. 1 to Tax Benefit Preservation Plan in Latest 8-K Filing - Minichart
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit By Investing.com - Investing.com India
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit - Investing.com Nigeria
Seer Amends Tax Benefit Plan After Stockholder Challenge - TipRanks
Seer (NASDAQ: SEER) updates tax benefit plan after Delaware action - Stock Titan
Aug PostEarnings: Will Seer Inc stock recover after earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Setup Watch: What is the target price for Seer Inc stock2025 Market WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
Aug Sectors: Is now the right time to enter Seer IncWeekly Gains Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Sentiment Watch: Whats the fair value of AEV CL stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
2.62%
2.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):